Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001209191-18-055385

Director bought 30,000 shares at $18.00 ($540,000)

  • Director acquired 74,870 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Humer Franz B · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-10-15 Purchase : show line 1 in the form +30,000 $18.00 $540,000 30,000 D
2018-10-15 Conversion : show line 2 in the form +74,870 104,870 D
Open-market purchases · 30,000 sh · avg $18.00 · $540,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-10-15 Conversion : show line 3 in the form Series A Convertible Preferred Stock −14,261 0 D
Loading xslF345X03/doc4.xml…